HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure patients: which AFib treatment works best?
Disease control Recruiting nowThis study looks at two ways to treat atrial fibrillation (an irregular heartbeat) in people who also have heart failure with preserved heart function. Participants will be randomly assigned to either a procedure called catheter ablation to restore normal rhythm, or medications t…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated May 17, 2026 09:23 UTC
-
New drug aims to cut heart failure hospitalizations in obese patients
Disease control Recruiting nowThis study tests a new drug, maridebart cafraglutide, in about 5,000 adults with heart failure and obesity. The goal is to see if it reduces heart failure events like hospitalizations and improves symptoms. Participants receive the drug or a placebo alongside standard care.
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Blood test may spot hidden heart risk in diabetes patients
Knowledge-focused Recruiting nowThis study aims to find early warning signs of heart failure in people with type 2 diabetes and metabolic syndrome. Researchers will analyze blood cells from 175 participants to see if certain signals can predict heart problems before they become serious. The goal is to improve d…
Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC